Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium

被引:41
作者
Zoltick, Emilie S. [1 ,2 ]
Linderman, Michael D. [3 ,4 ]
McGinniss, Molly A. [5 ]
Ramos, Erica [6 ]
Ball, Madeleine P. [7 ]
Church, George M. [7 ,8 ,9 ,10 ]
Leonard, Debra G. B. [11 ]
Pereira, Stacey [12 ]
McGuire, Amy L. [12 ]
Caskey, C. Thomas [13 ]
Sanderson, Saskia C. [4 ,14 ]
Schadt, Eric E. [4 ]
Nielsen, Daiva E. [1 ,15 ]
Crawford, Scott D. [16 ]
Green, Robert C. [1 ,17 ,18 ,19 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Genet, 41 Ave Louis Pasteur,Suite 301, Boston, MA 02115 USA
[2] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, 801 Massachusetts Ave,Suite 470, Boston, MA 02118 USA
[3] Middlebury Coll, Dept Comp Sci, McCardell Bicentennial Hall, Middlebury, VT 05753 USA
[4] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, One Gustave L Levy Pl,Box 1498, New York, NY 10029 USA
[5] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA
[6] Geisinger, Geisinger Natl Precis Hlth, 6101 Execut Blvd,Suite 110, North Bethesda, MD 20852 USA
[7] Open Humans Fdn, Boston, MA USA
[8] Harvard Med Sch, Harvard Personal Genome Project, Boston, MA USA
[9] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur,Room 238, Boston, MA 02115 USA
[10] Harvard Univ, Wyss Inst Biol Inspired Engn, 3 Blackfan Circle, Boston, MA 02115 USA
[11] Univ Vermont, Robert Larner MD Coll Med, Dept Pathol & Lab Med, 89 Beaumont Ave,Courtyard Given S269, Burlington, VT 05405 USA
[12] Baylor Coll Med, Ctr Med Eth & Hlth Policy, One Baylor Plaza,Suite 310D, Houston, TX 77030 USA
[13] Baylor Coll Med, Mol & Human Genet, One Baylor Plaza,Mail Stop BCM225, Houston, TX 77030 USA
[14] UCL, Dept Behav Sci & Hlth, Gower St, London WC1E 6BT, England
[15] McGill Univ, Sch Human Nutr, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada
[16] SoundRocket, 950 Victors Way,Suite 50, Ann Arbor, MI 48108 USA
[17] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA
[18] Harvard Med Sch, Boston, MA USA
[19] Partners HealthCare Personalized Med, Boston, MA 02115 USA
基金
加拿大健康研究院;
关键词
Personal genome sequencing; Return of results; Genomics; Test utility; Public health; PRIMARY-CARE PROVIDERS; CONSUMER PERCEPTIONS; CLINICAL EXOME; RISK; RECOMMENDATIONS; INTEGRATION; MEDICINE; SERVICES; BARRIERS; GENETICS;
D O I
10.1186/s13073-019-0619-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundIncreasing numbers of healthy individuals are undergoing predispositional personal genome sequencing. Here we describe the design and early outcomes of the PeopleSeq Consortium, a multi-cohort collaboration of predispositional genome sequencing projects, which is examining the medical, behavioral, and economic outcomes of returning genomic sequencing information to healthy individuals.MethodsApparently healthy adults who participated in four of the sequencing projects in the Consortium were included. Web-based surveys were administered before and after genomic results disclosure, or in some cases only after results disclosure. Surveys inquired about sociodemographic characteristics, motivations and concerns, behavioral and medical responses to sequencing results, and perceived utility.ResultsAmong 1395 eligible individuals, 658 enrolled in the Consortium when contacted and 543 have completed a survey after receiving their genomic results thus far (mean age 53.0years, 61.4% male, 91.7% white, 95.5% college graduates). Most participants (98.1%) were motivated to undergo sequencing because of curiosity about their genetic make-up. The most commonly reported concerns prior to pursuing sequencing included how well the results would predict future risk (59.2%) and the complexity of genetic variant interpretation (56.8%), while 47.8% of participants were concerned about the privacy of their genetic information. Half of participants reported discussing their genomic results with a healthcare provider during a median of 8.0months after receiving the results; 13.5% reported making an additional appointment with a healthcare provider specifically because of their results. Few participants (<10%) reported making changes to their diet, exercise habits, or insurance coverage because of their results. Many participants (39.5%) reported learning something new to improve their health that they did not know before. Reporting regret or harm from the decision to undergo sequencing was rare (<3.0%).ConclusionsHealthy individuals who underwent predispositional sequencing expressed some concern around privacy prior to pursuing sequencing, but were enthusiastic about their experience and not distressed by their results. While reporting value in their health-related results, few participants reported making medical or lifestyle changes.
引用
收藏
页数:13
相关论文
共 57 条
  • [1] Genetic identification of familial hypercholesterolemia within a single US health care system
    Abul-Husn, Noura S.
    Manickam, Kandamurugu
    Jones, Laney K.
    Wright, Eric A.
    Hartzel, Dustin N.
    Gonzaga-Jauregui, Claudia
    O'Dushlaine, Colm
    Leader, Joseph B.
    Kirchner, H. Lester
    Lindbuchler, D'Andra M.
    Barr, Marci L.
    Giovanni, Monica A.
    Ritchie, Marylyn D.
    Overton, John D.
    Reid, Jeffrey G.
    Metpally, Raghu P. R.
    Wardeh, Amr H.
    Borecki, Ingrid B.
    Yancopoulos, George D.
    Baras, Aris
    Shuldiner, Alan R.
    Gottesman, Omri
    Ledbetter, David H.
    Carey, David J.
    Dewey, Frederick E.
    Murray, Michael F.
    [J]. SCIENCE, 2016, 354 (6319)
  • [2] The promise and peril of genomic screening in the general population
    Adams, Michael C.
    Evans, James P.
    Henderson, Gail E.
    Berg, Jonathan S.
    [J]. GENETICS IN MEDICINE, 2016, 18 (06) : 593 - 599
  • [3] [Anonymous], PREC MED IN COH PROG
  • [4] [Anonymous], 2003, DIFFUSION INNOVATION
  • [5] Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI [10.1056/NEJMra1312543, 10.1056/NEJMc1408914]
  • [6] The ClinSeq Project: Piloting large-scale genome sequencing for research in genomic medicine
    Biesecker, Leslie G.
    Mullikin, James C.
    Facio, Flavia M.
    Turner, Clesson
    Cherukuri, Praveen F.
    Blakesley, Robert W.
    Bouffard, Gerard G.
    Chines, Peter S.
    Cruz, Pedro
    Hansen, Nancy F.
    Teer, Jamie K.
    Maskeri, Baishali
    Young, Alice C.
    Manolio, Teri A.
    Wilson, Alexander F.
    Finkel, Toren
    Hwang, Paul
    Arai, Andrew
    Remaley, Alan T.
    Sachdev, Vandana
    Shamburek, Robert
    Cannon, Richard O.
    Green, Eric D.
    [J]. GENOME RESEARCH, 2009, 19 (09) : 1665 - 1674
  • [7] Consumer perceptions of direct-to-consumer personalized genomic risk assessments
    Bloss, Cinnamon S.
    Ornowski, Laura
    Silver, Elana
    Cargill, Michele
    Vanier, Vance
    Schork, Nicholas J.
    Topol, Eric J.
    [J]. GENETICS IN MEDICINE, 2010, 12 (09) : 556 - 566
  • [8] Validation of a decision regret scale
    Brehaut, JC
    O'Connor, AM
    Wood, TJ
    Hack, TF
    Siminoff, L
    Gordon, E
    Feldman-Stewart, D
    [J]. MEDICAL DECISION MAKING, 2003, 23 (04) : 281 - 292
  • [9] Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers
    Carere, Deanna Alexis
    Couper, Mick P.
    Crawford, Scott D.
    Kalia, Sarah S.
    Duggan, Jake R.
    Moreno, Tanya A.
    Mountain, Joanna L.
    Roberts, J. Scott
    Green, Robert C.
    [J]. GENOME MEDICINE, 2014, 6
  • [10] The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research
    Carey, David J.
    Fetterolf, Samantha N.
    Davis, Daniel
    Faucett, William A.
    Kirchner, H. Lester
    Mirshahi, Uyenlinh
    Murray, Michael F.
    Smelser, Diane T.
    Gerhard, Glenn S.
    Ledbetter, David H.
    [J]. GENETICS IN MEDICINE, 2016, 18 (09) : 906 - 913